Taken together, both outcomes of the cell fusion assay and the hACE2-RBD sVNT assay indicate that the antiviral effects of HP1 and hypericin likely do not depend on any interference with the SARS-CoV-2 spike protein that would result in loss of S protein functions needed for virus infection. This evidence concerns the gene PROS1 and viral infectious disease.